• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期胃肠道癌患者接触相系统成分的研究。

Studies on components of the contact phase system in patients with advanced gastrointestinal cancer.

作者信息

Roeise O, Sivertsen S, Ruud T E, Bouma B N, Stadaas J O, Aasen A O

机构信息

Department of Surgery, Ullevaal Hospital, University of Oslo, Norway.

出版信息

Cancer. 1990 Mar 15;65(6):1355-9. doi: 10.1002/1097-0142(19900315)65:6<1355::aid-cncr2820650618>3.0.co;2-1.

DOI:10.1002/1097-0142(19900315)65:6<1355::aid-cncr2820650618>3.0.co;2-1
PMID:1689607
Abstract

The authors have studied components of the contact system in plasma obtained from patients with advanced gastrointestinal cancer. Plasma samples from 118 healthy blood donors served as controls. Plasma prekallikrein (PKK) values, evaluated by chromogenic peptide substrate technique, were significantly decreased in patients with cancer compared with healthy blood donors. High molecular weight kininogen (HMwK) and Hageman factor (FXII) values, assayed by immunochemical techniques, were also decreased in the patients with cancer. The changes of contact factors were most pronounced in patients with liver metastasis. The most striking observation in our study, however, was the elevated inhibitor values in patients with cancer. Alpha-2-macroglobulin (alpha 2-M) and C1 inhibitor (C1INH) values, determined both by functional and immunochemical techniques, were markedly increased in patients with cancer. In conclusion, this study shows that patients with intestinal cancer have reduced values of contact factors and markedly elevated inhibitor values which indicate that development of malignant tumors in the gastrointestinal tract is associated with changes in the contact system of plasma.

摘要

作者研究了晚期胃肠道癌患者血浆中接触系统的成分。来自118名健康献血者的血浆样本作为对照。通过发色肽底物技术评估的血浆前激肽释放酶(PKK)值,与健康献血者相比,癌症患者显著降低。通过免疫化学技术测定的高分子量激肽原(HMwK)和哈格曼因子(FXII)值在癌症患者中也降低。接触因子的变化在肝转移患者中最为明显。然而,我们研究中最显著的观察结果是癌症患者中抑制剂值升高。通过功能和免疫化学技术测定的α-2-巨球蛋白(α2-M)和C1抑制剂(C1INH)值在癌症患者中显著增加。总之,本研究表明,肠道癌患者接触因子值降低而抑制剂值显著升高,这表明胃肠道恶性肿瘤的发生与血浆接触系统的变化有关。

相似文献

1
Studies on components of the contact phase system in patients with advanced gastrointestinal cancer.晚期胃肠道癌患者接触相系统成分的研究。
Cancer. 1990 Mar 15;65(6):1355-9. doi: 10.1002/1097-0142(19900315)65:6<1355::aid-cncr2820650618>3.0.co;2-1.
2
Dose dependence of endotoxin-induced activation of the plasma contact system: an in vitro study.内毒素诱导血浆接触系统激活的剂量依赖性:一项体外研究。
Circ Shock. 1988 Dec;26(4):419-30.
3
Peritoneal lavage efficiently eliminates protease-alpha-2-macroglobulin complexes and components of the contact system from the peritoneal cavity in patients with severe acute pancreatitis.
Eur Surg Res. 1989;21(1):1-10. doi: 10.1159/000128997.
4
Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.对正常个体和脓毒性休克患者血浆样本中血浆激肽释放酶-激肽系统成分的研究。
Adv Shock Res. 1980;4:1-10.
5
Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC).疑似弥散性血管内凝血(DIC)的危重症患者的血浆前激肽释放酶、因子 XII、抗凝血酶 III、C1(-)抑制剂和α2-巨球蛋白
Am J Clin Pathol. 1984 Oct;82(4):396-404. doi: 10.1093/ajcp/82.4.396.
6
Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock.单纯性菌血症或细菌性休克中Hageman因子依赖性途径和补体系统的激活与抑制
J Infect Dis. 1985 Jun;151(6):1019-27. doi: 10.1093/infdis/151.6.1019.
7
Prekallikrein, HMW-kininogen and factor XII in various disease states.不同疾病状态下的前激肽释放酶、高分子量激肽原和因子 XII 。
Thromb Res. 1983 Jul 15;31(2):351-64. doi: 10.1016/0049-3848(83)90336-5.
8
Prognostic value of assessing contact system activation and factor V in systemic inflammatory response syndrome.评估接触系统激活和因子V在全身炎症反应综合征中的预后价值。
Crit Care Med. 1995 Jan;23(1):41-51. doi: 10.1097/00003246-199501000-00010.
9
Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease.慢性肝病中的Hageman因子、高分子量激肽原和前激肽释放酶
J Clin Pathol. 1986 Sep;39(9):1003-5. doi: 10.1136/jcp.39.9.1003.
10
[Plasma kallikrein-kinin system in hypercoagulable state (author's transl)].高凝状态下的血浆激肽释放酶-激肽系统(作者译)
Rinsho Ketsueki. 1980 Jun;21(6):704-13.

引用本文的文献

1
Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development.用于mRNA疫苗开发的肝细胞癌肿瘤抗原和免疫亚型的鉴定。
World J Gastrointest Oncol. 2023 Oct 15;15(10):1717-1738. doi: 10.4251/wjgo.v15.i10.1717.
2
Integrating Proteomics and Lipidomics for Evaluating the Risk of Breast Cancer Progression: A Pilot Study.整合蛋白质组学和脂质组学以评估乳腺癌进展风险:一项初步研究。
Biomedicines. 2023 Jun 22;11(7):1786. doi: 10.3390/biomedicines11071786.
3
Protein Biomarker Discovery Studies on Urinary sEV Fractions Separated with UF-SEC for the First Diagnosis and Detection of Recurrence in Bladder Cancer Patients.
基于 UF-SEC 分离的尿 sEV 级分的蛋白质生物标志物发现研究用于膀胱癌患者的首次诊断和复发检测。
Biomolecules. 2023 Jun 1;13(6):932. doi: 10.3390/biom13060932.
4
Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment.补体与真菌失调作为 PDAC 治疗的预后标志物和潜在靶点。
Curr Oncol. 2022 Dec 14;29(12):9833-9854. doi: 10.3390/curroncol29120773.
5
F12 as a reliable diagnostic and prognostic biomarker associated with immune infiltration in papillary thyroid cancer.F12 作为一种与甲状腺乳头状癌免疫浸润相关的可靠诊断和预后生物标志物。
Aging (Albany NY). 2022 Apr 28;14(8):3687-3704. doi: 10.18632/aging.204037.
6
The contact system in liver injury.肝脏损伤中的接触系统。
Semin Immunopathol. 2021 Aug;43(4):507-517. doi: 10.1007/s00281-021-00876-7. Epub 2021 Jun 14.
7
Protease: Serpin complexes to assess contact system and intrinsic pathway activation.蛋白酶:丝氨酸蛋白酶抑制剂复合物用于评估接触系统和内源性途径激活。
Res Pract Thromb Haemost. 2020 Jun 25;4(5):789-798. doi: 10.1002/rth2.12389. eCollection 2020 Jul.
8
Mechanisms and biomarkers of cancer-associated thrombosis.癌症相关血栓形成的机制和生物标志物。
Transl Res. 2020 Nov;225:33-53. doi: 10.1016/j.trsl.2020.06.012. Epub 2020 Jul 6.
9
The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues.胰腺癌与高凝状态的关系:流行病学和生物学问题的综合述评。
Br J Cancer. 2019 Aug;121(5):359-371. doi: 10.1038/s41416-019-0510-x. Epub 2019 Jul 22.
10
Complement in Pancreatic Disease-Perpetrator or Savior?补体在胰腺疾病中——是加害者还是拯救者?
Front Immunol. 2017 Jan 17;8:15. doi: 10.3389/fimmu.2017.00015. eCollection 2017.